Stryker completes acquisition of care.ai
Stryker (NYSE: SYK) has completed the acquisition of care.ai, a privately held company specializing in AI-assisted virtual care workflows, smart room technology, and ambient intelligence solutions. This acquisition is expected to strengthen Stryker's growing healthcare IT offering and wirelessly connected medical device portfolio. Andy Pierce, Group President of MedSurg and Neurotechnology at Stryker, expressed enthusiasm about accelerating the company's digital vision to provide customers with real-time, smart, and connected decision-making tools that can enhance the lives of caregivers and their patients. The acquisition aligns with Stryker's strategy to expand its technological capabilities in the healthcare sector.
Stryker (NYSE: SYK) ha completato l'acquisizione di care.ai, un'azienda privata specializzata in flussi di lavoro per la cura virtuale assistita da IA, tecnologia delle stanze intelligenti e soluzioni di intelligenza ambientale. Si prevede che questa acquisizione rafforzi l'offerta in crescita di Stryker nel settore IT sanitario e il portafoglio di dispositivi medici connessi senza fili. Andy Pierce, Presidente del Gruppo MedSurg e Neurotecnologia di Stryker, ha espresso entusiasmo per l'accelerazione della visione digitale dell'azienda per fornire ai clienti strumenti di decisione intelligenti e connessi in tempo reale che possono migliorare la vita dei caregiver e dei loro pazienti. L'acquisizione è in linea con la strategia di Stryker di espandere le proprie capacità tecnologiche nel settore sanitario.
Stryker (NYSE: SYK) ha completado la adquisición de care.ai, una empresa privada especializada en flujos de trabajo de atención virtual asistida por IA, tecnología de salas inteligentes y soluciones de inteligencia ambiental. Se espera que esta adquisición fortalezca la creciente oferta de Stryker en tecnología de la información para la salud y su portafolio de dispositivos médicos conectados de forma inalámbrica. Andy Pierce, Presidente del Grupo MedSurg y Neurotecnología de Stryker, expresó su entusiasmo por acelerar la visión digital de la empresa para proporcionar a los clientes herramientas de toma de decisiones inteligentes y conectadas en tiempo real que pueden mejorar la vida de los cuidadores y sus pacientes. La adquisición se alinea con la estrategia de Stryker para expandir sus capacidades tecnológicas en el sector de la salud.
Stryker (NYSE: SYK)는 care.ai의 인수를 완료했습니다. 이 회사는 AI 지원 가상 의료 워크플로우, 스마트룸 기술 및 주변 지능 솔루션을 전문으로 하는 비상장 기업입니다. 이 인수는 Stryker의 성장하는 헬스케어 IT 제공과 무선 연결 의료 기기 포트폴리오를 강화할 것으로 기대됩니다. Stryker의 MedSurg 및 Neurotechnology 그룹 사장인 Andy Pierce는 고객에게 실시간으로 스마트하고 연결된 의사결정 도구를 제공하겠다는 회사의 디지털 비전을 가속화하는 것에 대해 열정을 표현했습니다. 이 인수는 Stryker의 헬스케어 부문의 기술적 역량을 확장하려는 전략과 일치합니다.
Stryker (NYSE: SYK) a achevé l'acquisition de care.ai, une entreprise privée spécialisée dans les flux de travail de soins virtuels assistés par IA, la technologie de chambre intelligente et les solutions d'intelligence ambiante. Cette acquisition devrait renforcer l'offre croissante de Stryker en matière d'IT de santé et son portefeuille de dispositifs médicaux connectés sans fil. Andy Pierce, Président du Groupe MedSurg et Neurotechnologie chez Stryker, a exprimé son enthousiasme pour l'accélération de la vision numérique de l'entreprise, visant à fournir aux clients des outils de prise de décision intelligents et connectés en temps réel qui peuvent améliorer la vie des soignants et de leurs patients. L'acquisition est en accord avec la stratégie de Stryker d'élargir ses capacités technologiques dans le secteur de la santé.
Stryker (NYSE: SYK) hat die Übernahme von care.ai abgeschlossen, einem privat geführten Unternehmen, das sich auf KI-unterstützte virtuelle Pflegeabläufe, intelligente Raumtechnologie und Lösungen für umgebende Intelligenz spezialisiert hat. Diese Übernahme wird voraussichtlich Strykers wachsendes Angebot im Bereich Gesundheits-IT und das Portfolio von drahtlos verbundenen Medizinprodukten stärken. Andy Pierce, Präsident der Gruppe MedSurg und Neurotechnologie von Stryker, äußerte seine Begeisterung über die beschleunigte digitale Vision des Unternehmens, um den Kunden echtzeitfähige, intelligente und vernetzte Entscheidungswerkzeuge zu bieten, die das Leben der Pflegekräfte und ihrer Patienten verbessern können. Die Übernahme stimmt mit Strykers Strategie überein, seine technologischen Fähigkeiten im Gesundheitssektor auszubauen.
- Acquisition strengthens Stryker's healthcare IT offering
- Expands Stryker's wirelessly connected medical device portfolio
- Enhances Stryker's capabilities in AI-assisted virtual care workflows
- Adds smart room technology and ambient intelligence solutions to Stryker's offerings
- None.
Insights
Stryker's acquisition of care.ai marks a strategic move into the rapidly growing healthcare IT and AI-assisted care market. This acquisition is likely to enhance Stryker's competitive position and potentially drive future revenue growth. While financial details aren't disclosed, the deal's impact on Stryker's balance sheet and near-term earnings is likely minimal given care.ai's private status and Stryker's size (
The acquisition aligns with the industry trend of integrating AI and smart technologies into healthcare solutions, potentially improving Stryker's product offerings and market share in the digital health space. Investors should monitor how quickly Stryker can integrate care.ai's technologies and translate them into tangible financial benefits.
The acquisition of care.ai significantly bolsters Stryker's technological capabilities in the healthcare IT sector. care.ai's AI-assisted virtual care workflows and ambient intelligence solutions represent cutting-edge technologies that can potentially revolutionize patient care and hospital operations. This move positions Stryker at the forefront of the digital transformation in healthcare, enabling them to offer more comprehensive, integrated solutions to healthcare providers.
The synergy between Stryker's existing medical device portfolio and care.ai's smart room technology could lead to innovative products that enhance patient outcomes and operational efficiency in healthcare settings. This acquisition could be a game-changer for Stryker in the competitive medical technology landscape.
Portage, Michigan, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), announced that it has completed the previously announced acquisition of care.ai, a privately held company specializing in delivering AI-assisted virtual care workflows, smart room technology and ambient intelligence solutions.
“We welcome the care.ai team to Stryker and look forward to working together to accelerate our digital vision to provide customers with real-time, smart and connected decision-making tools that can enhance the lives of caregivers and their patients,” stated Andy Pierce, Group President, MedSurg and Neurotechnology, Stryker.
The acquisition will strengthen Stryker’s growing healthcare IT offering and wirelessly connected medical device portfolio.
About Stryker
Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at www.stryker.com.
Media contact:
Meghan Menz
Sr. Director, Communications
meghan.menz@stryker.com
FAQ
What company did Stryker (SYK) acquire on September 17, 2024?
How will the care.ai acquisition benefit Stryker's (SYK) product portfolio?
What is the strategic importance of Stryker's (SYK) acquisition of care.ai?
Who commented on Stryker's (SYK) acquisition of care.ai?
